Quantitative changes in cytoskeletal and nuclear actins during cellular transformation

International Journal of Cancer

Volumn 70, Issue 4, 1997, Pages 423-429

  Rao, Jian Yu ^a,d   Bonner, Rebecca B ^a   Hurst, Robert E ^a,b   Liang, Yuan Yuan ^a   Reznikoff, Catherine A ^c   Hemstreet III, George P ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN;

ARTICLE; CARCINOGENICITY; CELL NUCLEUS; CONTROLLED STUDY; CYTOSKELETON; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIMIAN VIRUS 40; UROTHELIUM; VIRUS CELL TRANSFORMATION;

ACTINS; AMINOBIPHENYL COMPOUNDS; BLOTTING, NORTHERN; CARCINOGENS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CYTOPLASM; DIMETHYL SULFOXIDE; HL-60 CELLS; HUMANS; NUCLEAR PROTEINS; RNA, MESSENGER;

EID: 0031038057     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970207)70:4<423::AID-IJC9>3.0.CO;2-Y     Document Type: Article

References (48)

1. AMANKWAH, K.S. and DE BONI, U., Ultrastructural localization of filamentous actin within neuronal interphase nuclei in situ. Exp. Cell Res., 210, 315-325 (1994).
2. ANKENBAUER, T., KLEINSCHMIDT, J.A., WALSH, M.J., WEINER, O.H. and FRANKE, W.W., Identification of a widespread nuclear actin binding protein. Nature (Land.), 342, 822-825 (1989).
3. BISHOP, J.M., The molecular genetic of cancer. Science, 235, 305-311 (1987).
4. BLIKSTAD, I., MARKEY, F., CARLSSON, L., PERSSON, T. and LINDBERG, U., Selective assay of monomeric and filamentous actin in cell extracts, using inhibition of deoxyribonuclease I. Cell. 15, 935-943 (1978).
5. BOOKLAND, E., REZNIKOFF, C.A., LINDSTROM, M. and SWAMINATHAN, S., Induction of thioguanine-resistant mutations in human uroepithelial cells by 4-aminobiphenyl and its N-hydroxyderivatives. Cancer Res., 52, 1615-1621 (1992a).
6. BOOKLAND, E., SWAMINATHAN, S., OYASU, R., GILCHRIST, K., LINDSTROM, M. and REZNIKOFF, C.A., Tumorigenic transformation and neoplastic progression of human uroepithelial cells after exposure in vitro to 4-amino-biphenyl or its metabolites. Cancer Res., 52, 1606-1614 (1992b).
7. BOYLE, W.J. and BALUDA, M.A., Subnuclear associations of the v-myb oncogene product and actin are dependent on ionic strength during nuclear isolation. Mol. cell. Biol., 7, 3345-3348 (1987).
8. BREMER, J.W., BUSCH, H. and YEOMAN, L.C., Evidence for a species of nuclear actin distinct from cytoplasmic and muscles actins. Biochemistry, 20, 2013-2017 (1981).
9. CARTER, C.A., DOHERTY, M.M., RUSNAK, D.W., NETTESHEIM, P. and FERRIOLA, P.C., Alterations in the localization of F-actin. fibronectin. and thrompospondin occur prior to neoplastic transformation in rat tracheal epithelial cells. Exp. Cell Res., 212, 141-150 (1994).
10. COUTURE, J. and HANSEN, M., Recessive genes in tumorisenesis. Cancer Bull., 43, 41-50 (1991).
11. HEMSTREET, G.P., III, RAO, J.Y., HURST, R.E., BONNER, R.B., JONES, P.L., VAIDYA, A.M., FRADET, Y., MOON, R.C. and KELLOFF, G.J., Intermediate endpoint biomarkers for chemoprevention. [Review]. J. Cell. Biochem. (Suppl.), 161, 93-110 (1992).
12. HEMSTREET, G.P., RAO, J.Y., HURST, R.E., BONNER, R.B., WALISZEWSKI, P., GROSSMAN, H.B., LIEBERT, M. and BANE, B.L., G-actin as a risk factor and modulatable endpoint for cancer chemoprevention trials. J. Cell. Biochem. (Suppl), (1996).
13. JONES, P.L., O'HARE, C., BASS, R.A., RAO, J.Y., HEMSTREET, G.P. and HURST, R.E., Quantitative immunofluorescence, anti-ras p21 antibody specificity and cellular oncoprotein levels. Biochem. biophvs. Res. Comm., 167, 464-470 (1990).
14. KOLBER, M.A., BROSCHAT, K.O. and LANDA-GONZALEZ, B., Cytochalasin B induces cellular DNA fragmentation. FASEB J., 4, 3021-3027 (1990).
15. KOYASU, S., KADOWAKI, T., NISHIDA, E., TOBE, K., ABE, E., KASUGA, M., SAKAI, H. and YAHARA, I., Alteration in growth, cell morphology, and cyloskeletal structures of KB cells induced by epidermal growth factor and transforming growth factor-beta. Exp. Cell Res., 176, 107-116 (1988).
16. LACHAPELLE, M. and ALDRICH, H.C., Phalloidin-gold complexes: a new tool for ultrastructural localization of F-actin. J. Histochem. Cytochem., 36, 1197-1202 (1988).
17. LEAVITT, J., Discovery and characterization of two novel human cancer-related proteins using two-dimensional gel electrophoresis. Electrophoresis. 15, 345-357 (1994).
18. LEAVITT, J., NG, S.Y., AEBI, U., VARMA, M., LATTER, G., BURBECK, S., KEDES, L. and GUNNING, P., Expression of transfected mutant beta-actin genes: alterations of cell morphology and evidence for autoresulation in actin pools. Mol. cell. Biol., 7, 2457-2466 (1987).
19. LOMBARDI, L., BALLINARI, D. and BONGARZONE, I., Ultrastructural cytoskeleton alterations and modification of actin expression in the NIH/3T3 cell line after transformation with Ha-ras-activated oncocene. Cell Motil. Cytoskeleton, 15, 220-229 (1990).
20. LORETZ, L. and REZNIKOFF, C.A., Clonal growth of normal human uroepitheleal cells. In Vitro Cell Dev. Biol. 24, 333-342 (1988).
21. MCWHIRTER, J.R. and WANG, J.Y., An actin-hinding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias. EMBO J., 12, 1533-1546 (1993).
22. MILANKOV, K. and DE BONI, U., Cytochemical localization of actin and myosin acsregates in interphase nuclei in situ. Exp. Cell Res., 209, 189-199 (1993).
23. MILLER, C.A., COHEN, M.D. and COSTA. M., Completing of actin and other nuclear proteins to DNA by cis-diamminedichloroplatinum(II) and chromium compounds. Carcinogenesis, 12, 269-276 (1991).
24. NOBES, C.D. and HALL, A., Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with act in stress fibers, lamellipodia. and filopodia. Cell. 81, 53-62 (1995).
25. 1. Science, 269, 1270-1272 (1995).
26. PAINE, P.L., Diffusive and nondiffusive proteins in vivo. J. Cell Biol, 99, 188s-195s (1984).
27. PARFENOV, V.N., DAVIS, D.S., POCHUKALINA, G.N., SAMPLE, C.E., BUGAEVA, E.A. and MURTI, K.G., Nuclear actin filaments and their topological changes in frog oocytes. Exp. Cell Res., 217, 385-394 (1995).
28. PIENTA, K.J. and COFFEY, D.S., Type IV procollagen mRNA regulation: evidence for extracellular matrix/cytoskeleton/nuclear matrix interactions in human urothelium. J. Cell Biol., 49, 357-365 (1992).
29. PIENTA, K., PARTIN, A. and COFFEY, D.S., Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res., 49, 2525-2532 (1989).
30. POLLARD, T. and COOPER, J.A., Actin and actin-binding proteins. A critical evaluation of mechanisms and functions. Ann. Rev. Biochem., 55, 987-1035 (1986).
31. PRATT, C.I., KAO, C.H., WU, S.Q., GILCHRIST, K.W., OYASU, R. and REZNIKOFF, C.A., Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells. Cancer Res., 52, 688-695 (1992).
32. PURNELL, D.M., HEATFIELD, B.M., ANTHONY, R.L. and TRUMP, B.F., Immunohistochemistry of the cytoskeleton of human prostatic epithelium. Amer. J. Pathol., 126, 384-395 (1987).
33. RAO, K.M. and COHEN, H.J., Actin cytoskeletal network in agina and cancer. Mutation Res., 256, 139-148 (1991).
34. RAO, J.Y., HEMSTREET, G.P., HURST, R.E., BONNER, R.B., JONES, P.L., MIN, K.W. and FRADET, Y., Alterations in phenotypic biochemical markers in bladder epithelium durine tumorisenesis. Proc. natl. Acad. Sci. (Wash.), 90, 8287-8291 (1993).
35. RAO, J.Y., HEMSTREET, G.P., HURST, R.E., BONNER, R.B., MIN, K.W. and JONES, P.L., Cellular F-actin levels as a marker for cellular transformation: correlation with bladder cancer risk. Cancer Res., 51, 2762-2767 (1991).
36. RAO, J.Y., HURST, R.E., BALES, W.D., JONES, P.L., BASS, R.A., ARCHER, L.T. and HEMSTREET, G.P., Cellular f-actin levels as a marker for cellular transformation: relationship to cell division and differentiation. Cancer Res., 50, 2215-2220 (1990).
37. RIDLEY, A.J. and HALL, A., The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell, 70, 389-399 (1992).
38. RIDLEY, A.J., PATERSON, H.F., JOHNSTON, C.L., DIEKMANN, D. and HALL, A., The small GTP-binding protein rac regulates arowth factor-induced membrane ruffling. Cell. 70, 401-410 (1992).
39. ROBERTS, A.B. and SPORN, M.B., Mechanistic interrelationships between two superfamilies: the sleroid/retinoid receptors and transforming growth factor-beta. [Review]. Cancer Surv., 14, 205-220 (1992).
40. RUBIN, H., Adaptive evolution of degrees and kinds of neoplastic transformation in cell culture. Proc. nat. Acad. Sci. (Wash.), 89, 977-981 (1992).
41. RUBIN, H., Incipient and overt stages of neoplastic transformation. Proc. nat. Acad. Sci. (Wash.), 91, 12076-12080 (1994).
42. SCHEER, U., HINSSEN, H., FRANKE, W.W. and JOCKUSCH, B.M., Microinjection of actin-binding proteins and actin antibodies demonstrates involvement of nuclear actin in transcription of lampbrush chromosomes. Cell, 39, 111-122 (1984).
43. SCHLUSSEL, R.N., DROLLER, M.J. and LIU, B.C., Type IV procollagen mRNA regulation: evidence for extracellular matrix/cytoskeleton/nuclear matrix interactions in human urothelium. J. Urol., 146, 428-432 (1991).
44. SHYY, T.T., ASCH, B.B. and ASCH, H.L., Concurrent collapse of keratin filaments, aggregation of organelles. and inhibition of protein synthesis during the heat shock response in mammary epithelial cells. J. Cell Biol., 108, 997-1008 (1989).
45. TEMIN, H., Evolution of cancer genes as a mutation-driven process. Cancer Res., 48, 1697-1701 (1988).
46. TROSKO, J.E., CHANG, C.C., MADHUKAR, B.V. and OH. S.Y., Modulators of gap junction function: the scientific basis of epiaenetic toxicoloay. In Vitro Toxicology, 3, 9-26 (1990).
47. WEINBERG, R. A., Tumor suppressor genes. Science. 254, 1138-1145 (1991).
48. WESSELLS, N.K., SPOONER, B.S., ASH, J.F., BRADLEY, M.O., LUDUENA, M.A., TAYLOR, E.L., WRENN, J.T. and YAMADA, K.M., Microfilaments in cellular and development process. Science, 171, 135 (1971).